what is the newest glp 1 medication GLP-1 Agonists: A Comprehensive Overview GLP-1s for Weight Loss: What
Description
Mechanistically, GLP-1 signaling suppresses M1-associated genes while enhancing that of M2-related genes through activation of signal transducer and activator of transcription 3 (STAT3) (Wan and Sun, 2019)
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Gastroparesis: A condition where the stomach empties more slowly than normal

Common gastrointestinal side effects are the most frequently reported adverse reactions, particularly during treatment initiation and dose escalation: Nausea (affecting 2040% of patients initially) Vomiting and diarrhoea Constipation Abdominal discomfort or bloating These symptoms typically diminish over several weeks as tolerance develops

9 Tendons may be rigid with poorly organized collagen and decreased elasticity, which compromises their ability to tolerate load

Conclusion Clinical trial data from large, controlled studies demonstrate the efficacy and safety of GLP-1 agonists in terms of A1C reduction, beneficial effects on body weight, and a low risk for hypoglycemic events when used as monotherapy

Q2: Is it safe to use Semaglutide for weight loss if I dont have diabetes
